Interpace Biosciences, Inc.(IDXG)
Health Care Services
Lab Testing & Diagnostics
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2021-05-25 | Burnell Thomas W. President & CEO | Purchase | +10,855 | +100.00%10,855 | $8.68 | $94,221 | View SEC filing | |
| 2021-03-01 | Kamin Peter 10% Owner | Purchase | +83,250 | +11.91%781,956 | $3.12 | $260,105 | View SEC filing | |
| 2015-12-04 | Melillo Gerald R JR President, Sales Services | Sale | -6,775 | -2.47%267,121 | $0.78 | $5,282 | View SEC filing | |
| 2014-11-25 | Miao Graham G CFO | Purchase | +22,000 | +52.51%63,899 | $1.65 | $36,300 | View SEC filing | |
| 2014-11-12 | Lurker Nancy CEO | Purchase | +49,000 | +10.12%533,317 | $1.75 | $85,592 | View SEC filing | |
| 2014-11-12 | Melillo Gerald R JR President, Sales Services | Purchase | +5,000 | +11.24%49,469 | $1.58 | $7,900 | View SEC filing | |
| 2014-11-12 | Smith Jeffrey Edward VP of Corporate Development | Purchase | +200,000 | +37.43%734,388 | $1.75 | $349,950 | View SEC filing | |
| 2014-11-10 | Melillo Gerald R JR President, Sales Services | Purchase | +5,000 | +11.06%50,224 | $1.58 | $7,900 | View SEC filing | |
| 2014-11-07 | Belle Gerald P. Director | Purchase | +57,300 | +58.69%154,931 | $1.71 | $98,092 | View SEC filing | |
| 2014-11-07 | Lurker Nancy CEO | Purchase | +57,000 | +4.04%1,468,209 | $1.74 | $99,135 | View SEC filing | |
| 2013-11-19 | Belle Gerald P. Director | Purchase | +20,400 | +15.08%155,714 | $5.21 | $106,286 | View SEC filing | |
| 2010-11-19 | Belle Gerald P. Director | Purchase | +1,000 | +2.99%34,403 | $10.60 | $10,601 | View SEC filing | |
| 2009-08-24 | Smith Jeffrey Edward CFO | Purchase | +2,500 | +1.93%131,924 | $5.25 | $13,125 | View SEC filing | |
| 2009-08-18 | Lurker Nancy CEO | Purchase | +9,960 | +7.11%149,960 | $5.12 | $51,037 | View SEC filing | |
| 2009-08-12 | Belle Gerald P. Director | Purchase | +1,000 | +4.03%25,818 | $5.21 | $5,213 | View SEC filing | |
| 2009-05-15 | VECSI JAN MARTENS Director | Purchase | +5,000 | +21.00%28,813 | $3.37 | $16,832 | View SEC filing | |
| 2008-12-02 | Smith Jeffrey Edward CFO | Purchase | +50,000 | +81.17%111,597 | $4.00 | $200,000 | View SEC filing | |
| 2008-12-01 | RYAN FRANK J Director | Purchase | +6,000 | +78.35%13,658 | $4.00 | $24,000 | View SEC filing | |
| 2008-11-26 | VECSI JAN MARTENS Director | Purchase | +10,000 | +121.09%18,258 | $3.81 | $38,109 | View SEC filing | |
| 2008-11-25 | FEDERSPIEL JOHN Director | Purchase | +3,000 | +39.17%10,658 | $3.84 | $11,507 | View SEC filing | |
| 2008-06-30 | Smith Jeffrey Edward CEO | Purchase | +6,054 | +18.81%38,232 | $8.26 | $50,006 | View SEC filing | |
| 2008-06-13 | Marquard Michael CEO | Purchase | +2,500 | +1.79%142,194 | $7.99 | $19,971 | View SEC filing | |
| 2006-03-14 | JACOBSON BETH Former Exec VP & GC | Sale | -10,000 | -100.00%0 | $11.44 | $114,400 | View SEC filing | |
| 2005-06-15 | SULLIVAN STEPHEN J Director | Purchase | +450 | +100.00%450 | $11.63 | $5,232 | View SEC filing | |
| 2004-11-18 | SALDARINI CHARLES T Vice Chairman of Board and CEO | Sale | -31,180 | -100.00%0 | $24.73 | $771,090 | View SEC filing |
1-25 of 28